[Practical considerations on psychiatric and anesthetic effects, in electroconvulsive therapy, of a new triazolo-4-3-alpha-pyridine derivative (Trazodone)].
D000928:Antidepressive Agents / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D004565:Electroconvulsive Therapy; D005069:Evaluation Studies as Topic; D006801:Humans; D001523:Mental Disorders / Q000628:therapy; D011229:Preanesthetic Medication; D011674:Pulse / Q000187:drug effects; D011725:Pyridines / Q000627:therapeutic use*; D012119:Respiration / Q000187:drug effects; D013390:Succinylcholine / Q000627:therapeutic use; D014230:Triazoles / Q000627:therapeutic use*
D000928:Antidepressive Agents; D011725:Pyridines; D014230:Triazoles; D013390:Succinylcholine
Considerazioni pratiche sugli effetti psichiatrici ed anestesici nella terapia elettroconvulsivante, di un nuovo derivato del triazolo 4-3-alfa-piridina (Trazodone.